Details of toxic effects not reported other than lethal dose value
REFERENCE :
APTRDI Advances in Prostaglandin and Thromboxane Research. (New York, NY)
V.1-8, 1976-80. Volume(issue)/page/year: 4,157,1978
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
131 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
APTRDI Advances in Prostaglandin and Thromboxane Research. (New York, NY)
V.1-8, 1976-80. Volume(issue)/page/year: 4,157,1978
** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intramuscular
DOSE :
30 ug/kg
SEX/DURATION :
female 14 week(s) after conception
TOXIC EFFECTS :
Reproductive - Fertility - abortion
REFERENCE :
CCPTAY Contraception. (Geron-X, Inc., POB 1108, Los Altos, CA 94022) V.1-
1970- Volume(issue)/page/year: 11,533,1975
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
87 ug/kg
SEX/DURATION :
female 15-22 day(s) after conception
lactating female 21 day(s) post-birth
TOXIC EFFECTS :
Reproductive - Effects on Newborn - stillbirth
Reproductive - Effects on Newborn - live birth index (measured after birth)
Reproductive - Effects on Newborn - viability index (e.g., # alive at day 4
per # born alive)
REFERENCE :
APTRDI Advances in Prostaglandin and Thromboxane Research. (New York, NY)
V.1-8, 1976-80. Volume(issue)/page/year: 4,157,1978
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
DOSE :
87 ug/kg
SEX/DURATION :
female 15-22 day(s) after conception
lactating female 21 day(s) post-birth